Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Macrogenics (MGNX) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Macrogenics (MGNX) over the last 14 years, with Q3 2025 value amounting to -$80.1 million.

  • Macrogenics' Enterprise Value rose 5539.1% to -$80.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$80.1 million, marking a year-over-year increase of 5539.1%. This contributed to the annual value of -$182.8 million for FY2024, which is 8110.86% down from last year.
  • According to the latest figures from Q3 2025, Macrogenics' Enterprise Value is -$80.1 million, which was up 5539.1% from -$130.7 million recorded in Q2 2025.
  • Over the past 5 years, Macrogenics' Enterprise Value peaked at -$21.5 million during Q2 2022, and registered a low of -$224.3 million during Q1 2023.
  • Moreover, its 5-year median value for Enterprise Value was -$108.9 million (2022), whereas its average is -$125.8 million.
  • As far as peak fluctuations go, Macrogenics' Enterprise Value surged by 8863.89% in 2022, and later tumbled by 40658.16% in 2023.
  • Macrogenics' Enterprise Value (Quarter) stood at -$123.5 million in 2021, then rose by 11.81% to -$108.9 million in 2022, then increased by 7.28% to -$101.0 million in 2023, then tumbled by 81.11% to -$182.8 million in 2024, then surged by 56.18% to -$80.1 million in 2025.
  • Its Enterprise Value was -$80.1 million in Q3 2025, compared to -$130.7 million in Q2 2025 and -$145.6 million in Q1 2025.